Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Open Access
- 15 June 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 138 (12) , 4515-4523
- https://doi.org/10.4049/jimmunol.138.12.4515
Abstract
Two immunogenic, syngeneic murine tumors were used to analyze the immunopathological processes associated with the immune rejection of primary intraocular tumors. Intracameral inoculation of P91 mastocytoma, an immunogenic variant of P815 mastocytoma, into DBA/2 mice resulted in progressive tumor growth for several weeks before immune rejection eradicated the intraocular neoplasm. The histopathologic characteristics of the tumor rejection included: a) destruction of the vascular endothelium of the microvasculature feeding the tumor; b) ischemic bulk necrosis; c) extensive innocent bystander damage to normal ocular structures; and d) absence of direct inflammatory cell-to-tumor cell contact. Thus, the immunopathological features resembled a delayed-type hypersensitivity (DTH) lesion. A second intraocular tumor model was similarly studied. UV5C25 fibrosarcoma grew slowly in the eyes of syngeneic BALB/c hosts. In sharp contrast to P91 tumors, a mononuclear cellular infiltrate was prominent within the tumor. After 5 wk, the intraocular tumors were completely rejected without detectable damage to normal ocular structures. The rejection of UV5C25 tumors did not produce scar tissue, damage to vascular endothelium, bulk necrosis, or atrophy of the globe. Although tumor-specific cytotoxic T lymphocytes (CTL) and DTH responses were readily detected, there was no histological evidence for DTH-mediated tumor rejection. Moreover, in situ immunoperoxidase staining indicated that the majority of the infiltrating lymphocytes were CTL, based on their characteristic phenotype: Thy-1+, Lyt-2+. Furthermore, the growth of UV5C25 fibrosarcoma in athymic, natural killer (NK) cell competent BALB/c nude mice demonstrated progressive tumor growth without infiltrating host cells. Collectively, the results indicate that immunogenic intraocular tumors can undergo strikingly different patterns of immune rejection with profoundly different pathological consequences. In one case (P91), tumor rejection occurs by a process that strongly resembles DTH and produces extensive nonspecific damage to normal tissues, resulting in irrevocable loss of vision. In contrast, the second intraocular tumor undergoes an immune rejection that is characterized by precision and a notable absence of damage to normal ocular tissues. The weight of evidence presented here strongly supports the hypothesis that the latter form of tumor rejection is mediated by CTL. Thus, the immunologic pathway invoked for tumor rejection in the eye has a profound effect on the fate of this delicate organ and the preservation of vision.This publication has 35 references indexed in Scilit:
- THE ROLE OF T-CELL SETS IN THE REJECTION OF A METHYLCHOLANTHRENE-INDUCED SARCOMA (S1509A) IN SYNGENEIC MICE1981
- Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.The Journal of Experimental Medicine, 1980
- T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.The Journal of Experimental Medicine, 1980
- Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ‐specific determinants on high endothelial venulesEuropean Journal of Immunology, 1980
- T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.The Journal of Immunology, 1980
- Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.The Journal of Experimental Medicine, 1979
- A functional comparison of tumor cell killing by activated macrophages and natural killer cellsEuropean Journal of Immunology, 1979
- Role of Different T Cell Sets in the Rejection of Syngeneic Chemically Induced TumorsThe Journal of Immunology, 1979
- Spontaneous regression of retinoblastomaSurvey of Ophthalmology, 1977
- Ly phenotype of cytotoxic T cells for syngeneic tumor.The Journal of Experimental Medicine, 1976